# atack-immunotherapy-platform
Personalized alloreactive cellular immunotherapy platform based on Allogeneic Targeted Activated Cancer Killer cells (ATACK), developed from earlier IMAK concepts and enhanced with monoclonal antibody targeting of overexpressed tumor antigens.
